Level Bio
0.32 SEK
-3.05 %
Less than 1K followers
LEVBIO
Nordic SME
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-3.05 %
-15.43 %
-9.14 %
-19.29 %
+15.22 %
+3.58 %
-53.91 %
-63.45 %
-96.81 %
Level Bio operates in the medical technology sector. The company conducts research and development of patented technology that enables the identification of viruses and bacteria. The products are sold under several brands and through its own distributors, mainly to laboratories and research institutes. The largest operations are found in the Nordic market. The headquarters are located in Nacka.
Read moreMarket cap
21.75M SEK
Turnover
206.7 SEK
Revenue
25.1M
EBIT %
-32.19 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
19/2
2026
Annual report '25
All
Press releases
3rd party
ShowingAll content types
Delårsrapport för tredje kvartalet 2025 Level Bio AB (publ)
Level Bio AB: Inbjudan till presentation av Level Bios Q3-rapport 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools